<SEC-DOCUMENT>0001157523-13-004174.txt : 20130819
<SEC-HEADER>0001157523-13-004174.hdr.sgml : 20130819
<ACCEPTANCE-DATETIME>20130819160557
ACCESSION NUMBER:		0001157523-13-004174
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20130819
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130819
DATE AS OF CHANGE:		20130819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TOMI Environmental Solutions, Inc.
		CENTRAL INDEX KEY:			0000314227
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TO DWELLINGS & OTHER BUILDINGS [7340]
		IRS NUMBER:				591947988
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-09908
		FILM NUMBER:		131048371

	BUSINESS ADDRESS:	
		STREET 1:		9454 WILSHIRE BLVD.
		STREET 2:		PENTHOUSE
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		8005251698

	MAIL ADDRESS:	
		STREET 1:		9454 WILSHIRE BLVD.
		STREET 2:		PENTHOUSE
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ozone Man, Inc.
		DATE OF NAME CHANGE:	20071130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RPS GROUP INC
		DATE OF NAME CHANGE:	19940818

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN INC
		DATE OF NAME CHANGE:	19940818
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a50693629.htm
<DESCRIPTION>TOMI ENVIRONMENTAL SOLUTIONS, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2013 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <font style="font-size: 11pt; font-family: Times New Roman">UNITED STATES</font><font style="font-size: 11pt; font-family: Times New Roman"><br style="font-size: 11pt; font-family: Times New Roman"></font><font style="font-size: 11pt; font-family: Times New Roman">SECURITIES
      AND EXCHANGE COMMISSION</font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman">WASHINGTON,
      D.C. 20549</font><br><br><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman">FORM
      8-K</font><br><br><font style="font-size: 11pt; font-family: Times New Roman">CURRENT
      REPORT PURSUANT</font><br><font style="font-size: 11pt; font-family: Times New Roman">TO
      SECTION 13 OR 15(d) OF THE</font><br><font style="font-size: 11pt; font-family: Times New Roman">SECURITIES
      EXCHANGE ACT OF 1934</font><br><br><font style="font-size: 11pt; font-family: Times New Roman">August
      19, 2013</font><font style="font-size: 11pt; font-family: Times New Roman"><br style="font-size: 11pt; font-family: Times New Roman"></font><font style="font-size: 11pt; font-family: Times New Roman">Date
      of Report (Date of earliest event reported)</font><br><font style="font-size: 11pt"><br style="font-size: 11pt"></font><u><font style="font-size: 11pt; font-family: Times New Roman">TOMI
      ENVIRONMENTAL SOLUTIONS, INC.</font></u><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt; font-family: Times New Roman">(Exact
      Name of Registrant as Specified in its Charter)</font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><br>
    </p>
    <div style="text-align:center">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; margin-left:auto;margin-right:auto; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; padding-left: 0.0px" colspan="3" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>Florida</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px" colspan="3" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (State or Other Jurisdiction of Incorporation)
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 33%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 34%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 33%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>000-09908</u>
          </p>
        </td>
        <td style="width: 34%">

        </td>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>59-1947988</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission File Number)
          </p>
        </td>
        <td style="width: 34%">

        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (IRS Employer Identification No.)
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 33%">

        </td>
        <td style="width: 34%">

        </td>
        <td style="width: 33%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px" colspan="2" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>9454 Wilshire Boulevard, Penthouse, Beverly Hills, California</u>
          </p>
        </td>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>90212</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px" colspan="2" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Address of Principal Executive Offices)
          </p>
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 33%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Zip Code)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>
      <u>(800) 525-1698</u><br>(Registrant's Telephone Number, Including Area
      Code)<br>
    </p>
    <p>

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 9%" valign="top">
          <b>Item 8.01</b>
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 90%" valign="top">
          <b>Other Events.</b>
        </td>
      </tr>
    </table>
    </div>
    <p>
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On August 19, 2013, TOMI Environmental Solutions, Inc. (the
      &#8220;Company&#8221;) issued a press release announcing that it has contracted with
      DivInd for the manufacturing of SteraMist<sup>&#8482;</sup> products
      utilizing TOMI&#8217;s patented Binary Ionization Technology<sup>&#174;</sup>.
      A copy of the press release is attached hereto as Exhibit 99.1 and
      incorporated herein by reference.
    </p>
    <p style="white-space: nowrap">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 9%" valign="top">
          <b>Item 9.01</b>
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 90%" valign="top">
          <b>Financial Statements and Exhibits.</b>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          (a)
        </td>
        <td style="width: 2%">
          &#160;
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 88%" valign="top">
          Not Applicable.
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          (b)
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 88%" valign="top">
          Not Applicable.
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          (c)
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 88%" valign="top">
          Not Applicable.
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          (d)
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 88%" valign="top">
          Exhibits.
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 10%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Exhibit #</b></u>
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 88%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Description</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px; width: 10%" valign="top">
          99.1
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 15.0px; width: 88%" valign="top">
          Press Release dated August 19, 2013 announcing that the Company has
          contracted with DivInd for the manufacturing of SteraMist<sup>&#8482;</sup>
          products utilizing TOMI&#8217;s patented Binary Ionization Technology<sup>&#174;</sup>.
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt; font-family: Times New Roman"><b>SIGNATURES</b></font>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">
      <font style="font-size: 10pt; font-family: Times New Roman">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the Registrant
      has duly caused this report to be signed on its behalf by the
      undersigned, hereunto duly authorized.</font>
    </p>
    <p style="font-size: 10pt; text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%" cellspacing="0">
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 20%">

        </td>
        <td style="width: 24%">
          &#160;
        </td>
        <td style="text-align: left; padding-left: 0.0px" colspan="4" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            TOMI ENVIRONMENTAL SOLUTIONS, INC.
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 6%" valign="top">

        </td>
        <td style="width: 20%">

        </td>
        <td style="width: 24%">

        </td>
        <td style="width: 3%">

        </td>
        <td colspan="2">

        </td>
        <td style="width: 10%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 6%" valign="top">
          Date:
        </td>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 20%" valign="top">
          August 19, 2013
        </td>
        <td style="width: 24%">

        </td>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 3%" valign="top">
          By:
        </td>
        <td style="text-align: left; border-bottom: solid black 1.0pt; padding-left: 0.0px" colspan="2" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Halden Shane
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 20%">

        </td>
        <td style="width: 24%">

        </td>
        <td style="width: 3%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 5%" valign="top">
          Name:
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Halden Shane
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 20%">

        </td>
        <td style="width: 24%">

        </td>
        <td style="width: 3%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 5%" valign="top">
          Title:
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Principal Executive Officer
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <u><b>EXHIBIT INDEX</b></u><br><br>
    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman; width: 100%" cellspacing="0">
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Exhibit #</b></u>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 2%" valign="top">
          &#160;
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 86%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Description</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 12%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 86%" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px; width: 12%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            99.1
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 86%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Press Release dated August 19, 2013 announcing that the Company
            has contracted with DivInd for the manufacturing of SteraMist<sup>&#8482;</sup>
            products utilizing TOMI&#8217;s patented Binary Ionization Technology<sup>&#174;</sup>.
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a50693629ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2013 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>New
      Manufacturing Contract For SteraMist Hand-Held Applicator</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>TOMI</b></font><b><sup><font style="font-size: 12pt; font-family: Times New Roman">&#8482;</font></sup><font style="font-size: 12pt; font-family: Times New Roman">
      Selects DivInd To Ramp-Up the Manufacture of SteraMist</font><sup><font style="font-size: 12pt; font-family: Times New Roman">&#8482;</font></sup><font style="font-size: 12pt; font-family: Times New Roman">
      Products Utilizing TOMI&#8217;s Patented Binary Ionization Technology</font><sup><font style="font-size: 12pt; font-family: Times New Roman">&#174;</font></sup><font style="font-size: 12pt; font-family: Times New Roman">
      To Fulfill Customer Backlog</font></b>
    </p>
    <p>
      BEVERLY HILLS, Calif.--(BUSINESS WIRE)--August 19, 2013--TOMI
      Environmental Solutions (OTCQB: TOMZ) (<u>www.tomiesinc.com</u>), a
      Beverly Hills-based global bacteria decontamination and infectious
      disease control company, announced today that it has successfully
      launched its patented novel technology from the lab to manufacturing.
      TOMI<sup>&#8482;</sup> has contracted with DivInd (<u>www.divindtech.com</u>)
      for the manufacturing of SteraMist<sup>&#8482;</sup> products utilizing
      TOMI&#8217;s patented Binary Ionization Technology<sup>&#174;</sup>.
      This next-generation of high performing decontamination technology
      products made in this initial phase of contract manufacturing will be
      used to fulfill the existing TOMI<sup>&#8482;</sup> backlog of
      commercial purchase orders. DivInd is a high-end custom manufacturer of
      fine and specialty chemical products and instruments and is based in
      Chandler, Arizona.
    </p>
    <p>
      &#8220;We have successfully demonstrated the capabilities and competencies of
      our technology at TOMI&#8217;s seven large hospital clients that have been
      using SteraMist&#8482; and our Binary Ionization Technology&#174; process,&#8221; said
      Dr. Halden Shane, Chief Executive Officer of TOMI<sup>&#8482;</sup>.
      &#8220;This contract manufacturing relationship marks another important step
      in our strategic plan for the development of our product line. Forming a
      relationship with a well regarded contract manufacturer like DivInd will
      provide manufacturing capacity for TOMI<sup>&#8482;</sup> to fulfill
      current and anticipated sales of our technology. We believe this
      relationship significantly enhances the value of TOMI<sup>&#8482;</sup>
      on a going-forward basis.&#8221;
    </p>
    <p>
      &#8220;The DivInd team is excited to see and support the TOMI<sup>&#8482;</sup>
      team in reaching another key milestone in their business strategy,&#8221; said
      Jeff Wilmer, Director of Manufacturing of DivInd. &#8220;Both teams worked
      tirelessly and collaboratively to meet an aggressive project timeline to
      transition the BIT<sup>&#8482;</sup> technology from the lab to a
      manufacturing environment. We expect to continue to provide TOMI<sup>&#8482;</sup>
      with our support during ramp-up and manufacturing. DivInd plans to
      continue to support TOMI<sup>&#8482;</sup> so that it can advance as
      efficiently as possible through the manufacturing and sales process
      worldwide.&#8221;
    </p>
    <p>
      TOMI<sup>&#8482;</sup> is the owner of the Binary Ionization Technology<sup>&#174;</sup>&#160;which
      the Company acquired from an international U.S. defense contractor&#160;in
      April 2013&#160;(which said contractor specifically carved out a military
      sales exclusivity to the U.S.&#160;military and the militaries of other
      limited countries).
    </p>
    <p>
      This technology is a decontamination system that applies cold plasma
      activation to a low percentage hydrogen peroxide-based aerosol, which
      then produces a Reactive Oxygen Species (&#8220;ROS&#8221;) mist that deactivates
      organic compounds and quickly inactivates viruses and bacteria including
      bacterial spores (C. diff) as well as mold spores, other fungi and
      yeast, both in the air and on surfaces. Leaving no residue or noxious
      fumes, SteraMist<sup>&#8482;</sup> using BIT<sup>&#8482;</sup> provides
      fast-acting, broad-spectrum decontamination and is environmentally
      friendly and is safe for delicate medical equipment and computers.
      Binary Ionization Technology<sup>&#174;</sup> has been shown to
      effectively decontaminate weaponized biological agents such as Anthrax
      and chemical agents such as VX and Mustard gas when applied using
      properly developed protocols.
    </p>
    <div style="margin-left: 0pt; margin-bottom: 10pt; margin-right: 0pt; text-indent: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Commencing in April 2013, TOMI<sup>&#8482;</sup> initiated significant
      changes and improvements in its SteraMist<sup>&#8482;</sup> Product line
      and DivInd&#8217;s manufacturing technologies and flexibility enabled the
      accurate delivery platform to achieve a six-log consistent kill during
      the BIT<sup>&#8482;</sup> oxidation Reactive Oxygen Species (ROS)
      process.
    </p>
    <p>
      In addition to starting contract manufacturing, TOMI<sup>&#8482;</sup>
      is currently undergoing an expansion of its research and development
      laboratories, including the construction of a treatment hood to
      duplicate the SteraMist process and advance its current product line to
      meet future global production needs in the coming years.
    </p>
    <p>
      <b>About TOMI&#8482; Environmental Solutions, Inc.</b>
    </p>
    <p>
      TOMI<sup>&#8482;</sup> Environmental Solutions, Inc. (OTCQB: TOMZ) is a
      global bacteria decontamination and infectious disease control company,
      providing green energy-efficient environmental solutions for indoor
      surface decontamination through manufacturing, sales and licensing of
      our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone
      Generators and Ultra-Violet Germicidal Irradiation (&quot;UVGI&quot;) products and
      technologies.
    </p>
    <p>
      TOMI<sup>&#8482;</sup>&#8217;s products are designed to service a broad
      spectrum of commercial structures including medical facilities, office
      buildings, hotel and motel rooms, schools, restaurants, meat and produce
      processing facilities, military barracks, and athletic facilities. TOMI<sup>&#8482;</sup>&#8217;s
      products and services have also been used in single-family homes and
      multi-unit residences.
    </p>
    <p>
      TOMI&#8482; also develops training programs and application protocols for its
      clients and is a member in good standing with The American Biological
      Safety Association, The American Association of Tissue Banks,
      Association for Professionals in Infection Control and Epidemiology,
      Society for Healthcare Epidemiology of America, The Restoration Industry
      Association, Indoor Air Quality Association and The International Ozone
      Association.
    </p>
    <p>
      For additional product information, visit <u>www.tomiesinc.com</u> or
      contact us at <u>info@tomiesinc.com</u>.
    </p>
    <p>
      <b>Safe Harbor Statement under the Private Securities Litigation Reform
      Act of 1995</b>
    </p>
    <p>
      Certain written and oral statements made by us may constitute
      &#8220;forward-looking statements&#8221; as defined in the Private Securities
      Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;). Forward-looking
      statements are identified by such words and phrases as &#8220;we expect,&#8221;
      &#8220;expected to,&#8221; &#8220;estimates,&#8221; &#8220;estimated,&#8221; &#8220;current outlook,&#8221; &#8220;we look
      forward to,&#8221; &#8220;would equate to,&#8221; &#8220;projects,&#8221; &#8220;projections,&#8221; &#8220;projected to
      be,&#8221; &#8220;anticipates,&#8221; &#8220;anticipated,&#8221; &#8220;we believe,&#8221; &#8220;could be,&#8221; and other
      similar phrases. All statements addressing operating performance,
      events, or developments that we expect or anticipate will occur in the
      future, including statements relating to revenue growth, earnings,
      earnings-per-share growth, or similar projections, are forward-looking
      statements within the meaning of the Reform Act. Because they are
      forward-looking, they should be evaluated in light of important risk
      factors that could cause our actual results to differ materially from
      our anticipated results. The information provided in this document is
      based upon the facts and circumstances known at this time. We undertake
      no obligation to update these forward-looking statements after the date
      of this release.
    </p>
    <p>

    </p>
    <p>

    </p>
    <p>
      CONTACT:<br>TOMI&#8482; Environmental Solutions, Inc.<br>Dr. Halden
      Shane, Chairman of the Board &amp; Chief Executive Officer<br>(310)
      275-2255<br>(800) 525-1698<br>or<br>Investor Relations:<br>Syndicated
      Capital, Inc.<br>John T. Hillman, (310) 255-4445
    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
